Skip to main content
APUS logo

APUS · Apimeds Pharmaceuticals US, Inc. · Holdings

Track APUS — free
$1.81 +0.14 (+8.38%)
Market Cap
$2.47M
Shares
1.51M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 7
Total Value: $383,651
Total Shares: 426,282

Institutional Ownership Trend

5 quarters

Holder Concentration

Across 7 13F filers · Δ vs Mar 31, 2026
Top Holder
64.3%
Jun 2025 → Jun 2026 · range 0.0% – 64.3%
+3.2 pts
Top 5
96.8%
Jun 2025 → Jun 2026 · range 0.0% – 99.1%
−2.2 pts
Top 10
100.0%
Jun 2025 → Jun 2026 · range 0.0% – 100.0%
0.0 pts
HHI
4,476
Jun 2025 → Jun 2026 · range 0 – 4,476
Highly concentrated+176

Quarterly Activity

vs Mar 31, 2026
New
2
Increased
1
Decreased
2
Sold Out
1
Unchanged
2
Holder count: +1
Institutional value: -52.2%
Shares held: -5.0%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 7 of 7
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1894525 CUSIP 03771D201 Visit website